CardioDx Revenue and Competitors
Estimated Revenue & Valuation
- CardioDx's estimated annual revenue is currently $12.9M per year. 0
- CardioDx's total funding is $317.3M.
Employee Data
- 00
CardioDx's People
Name | Title | Email/Phone |
---|
CardioDx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is CardioDx?
Founded in 2004, CardioDx is a cardiovascular genomic diagnostics company located in Palo Alto, CA. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure.
keywords:Biotechnology$317.3M
Total Funding
N/A
Number of Employees
$12.9M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
CardioDx News
California molecular diagnostics company CardioDx unveiled new details of its initial public offering, slated to raise $92 million through shares priced at $14-$16 apiece. Once the IPO launches, CardioDx will trade on the Nasdaq stock market under the symbol "CDX." The company has not yet set ...
CardioDx, Inc., a Palo Alto, CA-based developer of cardiovascular genomic diagnostic solutions, has completed a $58m two-tranche equity financing. Backers include Temasek and existing investors Longitude Capital, Artiman Ventures, Kleiner, Perkins, Caufield & Byers, J.P. Morgan, Mohr Davidow Ve ...
CardioDx, a Palo Alto, CA-based cardiovascular genomic diagnostics company, has closed a $60m round of equity financing. New investors Longitude Capital, J.P. Morgan, Acadia Woods Partners, Artiman Ventures, and Bright Capital, as well as existing backers, which include Kleiner, Perkins, Caufie ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15.5M | 0 | N/A | $7.7M |
#2 | $1M | 0 | N/A | $64.4M |
#3 | $3.8M | 0 | N/A | $4.6M |
#4 | $40.5M | 0 | N/A | $75.5M |
#5 | $2.3M | 0 | N/A | $6M |